DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CMD-193
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Lewis Y antigen binding agent
CMD-193
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DTP-348
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms
Unknown
DTP-348
×
Maximum Phase:
1
First Approval:
None
UNII:
2HB46A9CNM
Molecule Type:
Small molecule
Molecular Formula:
C6H11N5O4S
Molecular Weight:
249.25
AlogP:
-1.11
PSA:
133.15
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
IBI-939
1
Unknown
Investigational
Unknown
Unknown
Lung Neoplasms; Neoplasms
T-cell immunoreceptor with Ig and ITIM domains inhibitor
IBI-939
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVID200
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AVID200
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELGEMTUMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
ELGEMTUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5F1CN52GFM
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
COMBRETASTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
COMBRETASTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7O62J06F18
Molecule Type:
Small molecule
Molecular Formula:
C18H22O6
Molecular Weight:
334.37
AlogP:
2.7
PSA:
77.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LY3415244
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3415244
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LMP-744
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
LMP-744
×
Maximum Phase:
1
First Approval:
None
UNII:
29BY7HQV0T
Molecule Type:
Small molecule
Molecular Formula:
C24H24N2O7
Molecular Weight:
452.46
AlogP:
1.93
PSA:
108.25
HBD:
2.0
HBA:
#RotB:
8.0
Source:
AZD-8055
1
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Carcinoma, Hepatocellular; Glioblastoma; Lymphoma; Neoplasms; Oligodendroglioma
Serine/threonine-protein kinase mTOR inhibitor
AZD-8055
×
Maximum Phase:
1
First Approval:
None
UNII:
970JJ37FPW
Molecule Type:
Small molecule
Molecular Formula:
C25H31N5O4
Molecular Weight:
465.55
AlogP:
2.64
PSA:
93.07
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CROBENETINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CROBENETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Q72DWI2G4C
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.91
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AZD-5438
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
AZD-5438
×
Maximum Phase:
1
First Approval:
None
UNII:
276Z913G29
Molecule Type:
Small molecule
Molecular Formula:
C18H21N5O2S
Molecular Weight:
371.47
AlogP:
3.38
PSA:
89.77
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VALINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VALINE
×
Maximum Phase:
1
First Approval:
None
UNII:
HG18B9YRS7
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO2
Molecular Weight:
117.15
AlogP:
0.05
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
2.0
Source:
AMV-564
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
Unknown
AMV-564
×
Maximum Phase:
1
First Approval:
None
UNII:
56FUB33G5M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
WP 1066
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
WP 1066
×
Maximum Phase:
1
First Approval:
None
UNII:
63V8AIE65T
Molecule Type:
Small molecule
Molecular Formula:
C17H14BrN3O
Molecular Weight:
356.22
AlogP:
3.63
PSA:
65.78
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GLIAL GROWTH FACTOR 2
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GLIAL GROWTH FACTOR 2
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEPRANEMAB
1
Antibody
Investigational
Unknown
Unknown
Supranuclear Palsy, Progressive; Alzheimer Disease
Unknown
BEPRANEMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
9M1GV6L389
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAY-1217389
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity protein kinase TTK inhibitor
BAY-1217389
×
Maximum Phase:
1
First Approval:
None
UNII:
M964LB1114
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-573
1
Unknown
Investigational
Unknown
Unknown
Melanoma; Multiple Myeloma
Unknown
TAK-573
×
Maximum Phase:
1
First Approval:
None
UNII:
TN8CEX4UT2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TP-3654
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TP-3654
×
Maximum Phase:
1
First Approval:
None
UNII:
EOB0N7BOY4
Molecule Type:
Small molecule
Molecular Formula:
C22H25F3N4O
Molecular Weight:
418.46
AlogP:
5.16
PSA:
62.45
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TAK-137
1
Unknown
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Unknown
TAK-137
×
Maximum Phase:
1
First Approval:
None
UNII:
XE1054JW00
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
APOCYNIN
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cardiovascular Diseases; Pulmonary Disease, Chronic Obstructive
Unknown
APOCYNIN
×
Maximum Phase:
1
First Approval:
None
UNII:
B6J7B9UDTR
Molecule Type:
Small molecule
Molecular Formula:
C9H10O3
Molecular Weight:
166.18
AlogP:
1.6
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PBF-999
1
Small molecule
Investigational
Unknown
Unknown
Huntington Disease; Neoplasms
Adenosine A2a receptor antagonist
PBF-999
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986104
1
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
BMS-986104
×
Maximum Phase:
1
First Approval:
None
UNII:
KJ9D084FO4
Molecule Type:
Small molecule
Molecular Formula:
C22H35NO
Molecular Weight:
329.53
AlogP:
4.72
PSA:
46.25
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
BEMOTRIZINOL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BEMOTRIZINOL
×
Maximum Phase:
1
First Approval:
None
UNII:
PWZ1720CBH
Molecule Type:
Small molecule
Molecular Formula:
C38H49N3O5
Molecular Weight:
627.83
AlogP:
9.48
PSA:
106.82
HBD:
2.0
HBA:
#RotB:
18.0
Source:
SYM-021
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SYM-021
×
Maximum Phase:
1
First Approval:
None
UNII:
K45ZNW8WU9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
93
94
95
96
97
98
99
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA